Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Current Deferred Revenue (2023 - 2025)

Vsee Health's Current Deferred Revenue history spans 3 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 217.0% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 217.0%, while the annual FY2025 figure was $1.3 million, 217.0% up from the prior year.
  • Current Deferred Revenue reached $1.3 million in Q4 2025 per VSEE's latest filing, up from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.3 million in Q4 2025 to a low of $87500.0 in Q2 2023.
  • Average Current Deferred Revenue over 3 years is $852956.8, with a median of $896083.5 recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: crashed 53.71% in 2024, then surged 217.0% in 2025.
  • A 3-year view of Current Deferred Revenue shows it stood at $902524.0 in 2023, then plummeted by 53.71% to $417815.0 in 2024, then soared by 217.0% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Current Deferred Revenue are $1.3 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025).